@article{article_409592, title={Vandetanib induced photoallergic dermatitis: A case report}, journal={Archives of Clinical and Experimental Medicine}, volume={3}, pages={94–96}, year={2018}, DOI={10.25000/acem.409592}, author={Yüce, Gurbet Acar and An, İsa and Esen, Mustafa and Akdeniz, Nadiye}, keywords={dermatitis,photoallergenic,vandetanib}, abstract={<p class="MsoNormal" style="text-align:justify;line-height:200%;"> <span lang="en-us" style="font-family:’Times New Roman’, serif;" xml:lang="en-us">Vandetanib is a multi-kinase inhibitor of epidermal growth factor receptor, vascular endothelial growth factor. Most common dermatological
side effects induced by vandetanib include papulopustular eruption, hand-foot
syndrome, and hyperpigmentation. </span> </p> <p> </p> <p class="MsoNormal" style="text-align:justify;line-height:200%;"> <span lang="en-us" style="font-family:’Times New Roman’, serif;" xml:lang="en-us">In this report, we present a case with metastatic medullar thyroid
carcinoma who developed vandetanib-induced photoallergic dermatitis. </span> </p> <p> </p>}, number={2}, publisher={Mustafa HASBAHÇECİ}